Rifampicin for Continuation Phase Tuberculosis Treatment in Uganda: A Cost-Effectiveness Analysis

BACKGROUND: In Uganda, isoniazid plus ethambutol is used for 6 months (6HE) during the continuation treatment phase of new tuberculosis (TB) cases. However, the World Health Organization (WHO) recommends using isoniazid plus rifampicin for 4 months (4HR) instead of 6HE. We compared the impact of a c...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Manabe, Yukari C., Hermans, Sabine M., Lamorde, Mohammed, Castelnuovo, Barbara, Mullins, C. Daniel, Kuznik, Andreas
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2012
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3377630/
https://ncbi.nlm.nih.gov/pubmed/22723960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0039187
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia